Results 141 to 150 of about 137,620 (287)
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
CRITICAL DISCOURSE ANALYSIS ON PRINTED CIGARRETTE ADVERTISEMENT
Sri Setyo Ariani
openalex +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Support Community Formation on a Mobile App for People Living With HIV and Substance Use Disorder: A Computer-Mediated Discourse Analysis. [PDF]
Tarfa A +6 more
europepmc +1 more source
THE LANGUAGE OF RELIGION AS DISCOURSE: ANALYSIS OF THE SYNTACTIC STRUCTURES IN PROVERBS CHAPTER NINE
AMEN V. UHUNMWANGHO +1 more
openalex +2 more sources
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Playing with our 'self' in medicine: A discourse analysis of 'self' exploration. [PDF]
Khan R.
europepmc +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source

